Role of endotoxin and nitric oxide in the pathogenesis of renal failure in obstructive jaundice

British Journal of Surgery

Volumn 84, Issue 7, 1997, Pages 943-947

  Inan, M ^a   Sayek, I ^a   Tel, B C ^a   Sahin Erdemli, I ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; ISOLATED KIDNEY; KIDNEY FAILURE; KIDNEY PERFUSION; MALE; NONHUMAN; OBSTRUCTIVE JAUNDICE; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; BILE DUCTS; BILIRUBIN; BLOOD PRESSURE; CHOLESTASIS; ENDOTOXEMIA; ENDOTOXINS; FEMALE; FORSKOLIN; KIDNEY; KIDNEY FAILURE, ACUTE; LIGATION; MALE; NITRIC OXIDE; NITROGLYCERIN; RATS; RATS, WISTAR; VASODILATION;

EID: 0030757248     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800840710     Document Type: Article

References (36)

1. Bailey ME. Endotoxin, bile salts and renal function in obstructive jaundice. Br J Surg 1976; 63: 774-8.
2. Cahill CJ. Prevention of postoperative renal failure in patients with obstructive jaundice - the role of bile salts. Br J Surg 1983; 70: 590-5.
3. Thompson JN, Edwards WH, Winerals CG, Blenkham JI, Benjamin IS, Blumgart LH. Renal impairment following biliary tract surgery. Br J Surg 1987; 74: 843-7.
4. Allison MEM, Prentice CRM, Kennedy AC, Blumgart LH. Renal function and other factors in obstructive jaundice. Br J Surg 1979; 66: 392-7.
5. Fogarty BJ, Parks RW, Rowlands BJ, Diamond T. Renal dysfunction in obstructive jaundice. Br J Surg 1995; 82: 877-84.
6. Odell GB, Natzschka JC, Storey GN. Bilirubin nephropathy in the Gunn strain of rat. Am J Physiol 1967; 212: 931-8.
7. Elias MM, Comin EJ, Grosman ME, Galeazzi SA, Rodriguez-Garay EA. Possible mechanism of unconjugated bilirubin toxicity on renal tissue. Comp Biochem Physiol A 1987; 87: 1003-7.
8. O'Neill P, Wait RB, Kahng KU. Obstructive jaundice and renal failure in the rat: the role of renal prostaglandins and the renin-angiotensin system. Surgery 1990; 108: 356-62.
9. Oms L, Martinez Rodenas F, Valverde J, Jimenez W, Sitges-Serra A. Reduced water and sodium intakes associated with high levels of natriuretic factor following common bile duct ligation in the rabbit. Br J Surg 1990; 77: 752-5.
10. Valverde J, Martinez Rodenas F, Pereira JA et al. Rapid increase in plasma levels of atrial natriuretic peptide after common bile duct ligation in the rabbit. Ann Surg 1992; 216: 554-9.
11. Bloom D, McCalden TA, Rosendorff C et al. Effects of jaundiced plasma on vascular sensitivity to noradrenalin. Kidney Int 1975; 8: 149-57.
12. 2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology 1991; 100: 1069-77.
13. Fletcher MS, Westwick J, Kakkar VV. Endotoxin, prostaglandins and renal fibrin deposition in obstructive jaundice. Br J Surg 1982; 69: 625-9.
14. Sitges-Serra A, Carulla Piera X, Rodenas FM et al. Body water compartments in patients with obstructive jaundice. Br J Surg 1992; 79: 553-6.
15. Epstein M. The hepatorenal syndrome - newer perspectives. N Engl J Med 1992; 327: 1810-11 (Editorial).
16. Green J, Beyar R, Sideman S, Mordechovitz D, Better OS. The 'jaundiced heart': a possible explanation for postoperative shock in obstructive jaundice. Surgery 1986; 100: 14-20.
17. Ozawa K, Yamada T, Tanaka J, Ukikusa M, Tobe T. The mechanism of suppression of renal function in patients and rabbits with jaundice. Surg Gynecol Obstet 1979; 149: 54-60.
18. Wardle EN, Wright NA. Endotoxin and acute renal failure associated with obstructive jaundice. BMJ 1970; 4: 472-4.
19. Wilkinson SP, Moodie H, Stamatakis JD, Kakkar VV, Williams R. Endotoxemia and renal failure in cirrhosis and obstructive jaundice. BMJ 1976; 2: 1415-18.
20. Cahill CJ, Pain JA, Bailey ME. Bile salts, endotoxin and renal function in obstructive jaundice. Surg Gynecol Obstet 1987; 165: 519-22.
21. Ghosh S, Latimer RD, Gray BM, Harwood RJ, Odura A. Endotoxin-induced organ injury. Crit Care Med 1993; 21 (2 Suppl): S19-24.
22. Valance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337: 776-8.
23. Rodeberg DA, Chaet MS, Bass RC, Arkovitz MS, Garcia VF. Nitric oxide: an overview. Am J Surg 1995; 170: 292-303.
24. Ochoa JB, Udekwu AO, Billiar TR et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214: 621-6.
25. Deitch EA, Sittig K, Li M, Berg R, Specian RD. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 1990; 159: 79-84.
26. Katz S, Grosfeld JL, Gross K et al. Impaired bacterial clearance and trapping in obstructive jaundice. Ann Surg 1984; 199: 14-20.
27. Tanaka N, Ryden S, Bergqvist L, Christensen P, Bengmark S. Reticulo-endothelial function in rats with obstructive jaundice. Br J Surg 1985; 72: 946-9.
28. Tanaka N, Christensen P, Ryden S, Klofver-Stahl B, Bengmark S. Decreased clearance of Escherichia coli from the bile in rats with obstructive jaundice. Eur Surg Res 1985; 17: 281-5.
29. Scott-Conner CEH, Grogan JB, Scher KS, Bernstein JM, Bailey-Berk C. Impaired bacterial killing in early obstructive jaundice. Am J Surg 1993; 166: 308-10.
30. Epstein M, Berk DP, Hollenberg NK et al. Renal failure in the patients with cirrhosis. The role of active vasoconstriction. Am J Med 1970; 49: 175-85.
31. Parker JL, Adams HR. Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ Res 1993; 72: 539-51.
32. Özsan K, Türker RK, Ercan ZS et al. Possible involvement of endothelin peptides and L-arginine-nitric oxide pathway on the effect of endotoxin in the rabbit isolated perfused kidney Med Inf (Lond) 1994; 3: 211-14.
33. Wylam ME, Samsel RW, Umans JG, Mitchell RW, Leff AR, Schumacker PT. Endotoxin in vivo impairs endothelium-dependent relaxation of canine arteries in vitro. Am Rev Respir Dis 1990; 142: 1263-7.
34. Parker JL, Adams HR. Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ Res 1993; 72: 539-51.
35. Waldman SA, Rapoport RM, Ginsburg R, Murad F. Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol 1986; 35: 3525-31.
36. Heuze Joubert I, Mennecier P, Simonet S, Laubie M, Verbeuren TJ. Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated perfused rat kidney. Eur J Pharmacol 1992; 220: 161-71.